Characterization of an induced pluripotent stem cell line (NCHi024-A) from a male infant with bicuspid aortic valve
Stem Cell Research · 2025
DOI: 10.1016/j.scr.2025.103751 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cell Research, 2025. Verfasst von Jiyoon Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cardiovascular Research, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, USA; The Heart Center, Nationwid…. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Aortic Valve, Heart Valve Diseases. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, American Heart Association-American Stroke Association, Additional Ventures LLC.
Abstract (Originalsprache)
Bicuspid aortic valve is one of the most common congenital heart defects which have only two leaflets instead of three. NCHi024-A is an induced pluripotent stem cell (iPSC) line derived from peripheral blood mononuclear cells (PBMCs) of a male infant with a bicuspid aortic valve. The line exhibits normal iPSC morphology, normal karyotype, and donor-matched identity. Markers of undifferentiated iPSC and differentiation into ectoderm, mesoderm, and endoderm were validated through immunofluorescence staining. NCHi024-A was tested negative for transgenes and mycoplasma contamination. This iPSC line can be differentiated into various types of cells and used for studying aortic valve disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Center for Cardiovascular Research, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, USA; The Heart Center, Nationwide Children's Hospital, Columbus, OH, USA.
- Center for Cardiovascular Research, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, USA; The Heart Center, Nationwide Children's Hospital, Columbus, OH, USA; Department of Pediatrics, Th…
Förderung
- NHLBI NIH HHS
- American Heart Association-American Stroke Association
- Additional Ventures LLC
- National Heart Lung and Blood Institute
- Animal Health Australia
- American Heart Association Inc
- National Institutes of Health
Zitieren
APA
Lee, J., Hanley, M., Ye, S., Yu, Y., Argall, A., & Zhao, M. T. (2025). Characterization of an induced pluripotent stem cell line (NCHi024-A) from a male infant with bicuspid aortic valve. Stem Cell Research. https://doi.org/10.1016/j.scr.2025.103751
Vancouver
Lee J, Hanley M, Ye S, Yu Y, Argall A, Zhao MT. Characterization of an induced pluripotent stem cell line (NCHi024-A) from a male infant with bicuspid aortic valve. Stem Cell Research. 2025. doi:10.1016/j.scr.2025.103751
BibTeX
@article{Lee2025,
author = {Lee, Jiyoon and Hanley, Meghan and Ye, Shiqiao and Yu, Yang and Argall, Aaron and Zhao, Ming-Tao},
title = {Characterization of an induced pluripotent stem cell line (NCHi024-A) from a male infant with bicuspid aortic valve},
journal = {Stem Cell Research},
year = {2025},
doi = {10.1016/j.scr.2025.103751}
}
EUVIMED